Key result
The production of an antipoliomyelitis serum in horses was explored based on the neutralizing power of convalescent serum and the potential etiologic role of a pleomorphic streptococcus.
This is the authors' abstract. We don't add key points for this paper.
It is a well established fact that the serum of patients and monkeys which have recovered from poliomyelitis has a neutralizing1and protective power2against the virus of poliomyelitis. Inoculations of virus as well as of cultures of the globoid organism3which fail to produce at least abortive attacks of poliomyelitis fail also to produce neutralizing and protective substances in the serum; hence immunity does not result. The recent work of Amoss4proves further that the globoid organisms of Flexner and Noguchi5have indeed little antigenic power. The need of immunization experiments along other lines in this disease is therefore apparent. A restudy of the bacteriology of poliomyelitis during the past epidemic has emphasized anew the possible rôle which bacteria of ordinary size may play in the etiology of this disease. A pleomorphic streptococcus or micrococcus having elective affinity for the central nervous system in
Answers are grounded in this paper and cite their sources.
Exploratory equine serum production leaves open therapeutic utility in polio; hypothesis-generating for convalescent neutralizing factors.
No takes yet. Share an insight, caveat, or question.
Edward C. Rosenow (1917) studied Poliomyelitis. Antipoliomyelitis serum was evaluated. The production of an antipoliomyelitis serum in horses was explored based on the neutralizing power of convalescent serum and the potential etiologic role of a pleomorphic streptococcus.
Synapse has enriched 10 related papers. Consider them for comparative context: